Research

Mixed

Gut microbiota manipulation via antibiotics, prebiotics, or probiotics improves metabolic parameters (insulin resistance, inflammation, fat mass) in animal models of obesity and NAFLD, though human data remains scarce and inconclusive.

While animal studies show that changing gut bacteria (via antibiotics, prebiotics, or probiotics) can improve metabolic health, human evidence is currently insufficient to recommend these as standard treatments. Focus on a balanced diet to support a healthy microbiome rather than seeking specific microbiota-altering supplements without medical guidance.

ModerateConditionalMEDIUM confidence
Gut microbiota manipulation through antibiotics, prebiotics and probiotics yields encouraging results for the treatment of obesity, diabetes and NAFLD in animal models, but data in humans are currently scarce.
Giovanni Musso et al. · Current Opinion in Lipidology · 2010

Why this rating

Strong animal data but limited and mixed human trials.

Source

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders

Giovanni Musso et al. · Current Opinion in Lipidology · 2010

DOI 10.1097/mol.0b013e3283347ebb

narrative_reviewCited 186×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →